Purpose: This study examined the effects of preoperative incentive spirometry (IS) education (POISE) on postoperative outcomes for knee and hip total joint replacement patients.
Design: In this prospective study, 140 patients were randomized to Group 1 (POISE intervention = 50 completing) or Group 2 (no intervention = 56 completing) (34 dropped).
Methods: The Group 1 intervention consisted of formal instruction preoperatively for IS home use, postoperative use, and IS volumes documentation. Group 2 patients received no intervention. Patients recorded postoperative IS volumes, which were used to determine return to baseline volume.
Findings: One hundred six patients completed the study. Most were Caucasian females averaging 64 years. Although IS return to baseline volume time was not significantly different between groups, POISE patients had fewer postoperative complications, hospital days, and charges. POISE patients ranked the intervention as helpful.
Conclusions: Although IS volumes were not significantly different between groups, POISE patients had better outcomes and ranked the intervention as helpful.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jopan.2013.01.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy.
Nanomaterials (Basel)
January 2025
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1X6, Canada.
Monte Carlo (MC) simulations have become important in advancing nanoparticle (NP)-based applications for cancer imaging and therapy. This review explores the critical role of MC simulations in modeling complex biological interactions, optimizing NP designs, and enhancing the precision of therapeutic and diagnostic strategies. Key findings highlight the ability of MC simulations to predict NP bio-distribution, radiation dosimetry, and treatment efficacy, providing a robust framework for addressing the stochastic nature of biological systems.
View Article and Find Full Text PDFThe time has come: discussing the clinical neuropsychology provider's role in cultural respect and inclusion.
J Clin Exp Neuropsychol
January 2025
Division of Psychology, Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
There has been both a national and global emphasis within the past 3 years to promote diversity, equity, inclusion (DEI), and cultural respect in healthcare and academia. One discipline and healthcare arena where this has been evident is the psychology field. Indeed, there has been rampant and widespread adoption and advancement of DEI and cultural respect across most of psychology.
View Article and Find Full Text PDFCurrent Status and Future Directions of Artificial Intelligence in Post-Traumatic Stress Disorder: A Literature Measurement Analysis.
Behav Sci (Basel)
December 2024
Department of Digital Media Art, School of Architecture and Urban Planning, Huazhong University of Science and Technology, Wuhan 430074, China.
This study aims to explore the current state of research and the applicability of artificial intelligence (AI) at various stages of post-traumatic stress disorder (PTSD), including prevention, diagnosis, treatment, patient self-management, and drug development. We conducted a bibliometric analysis using software tools such as Bibliometrix (version 4.1), VOSviewer (version 1.
View Article and Find Full Text PDFArtificial Intelligence Revolution in Pharmaceutical Sciences: Advancements, Clinical Impacts, and Applications.
Curr Pharm Biotechnol
January 2025
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Artificial intelligence (AI) is a rapidly transforming drug discovery and development process, significantly impacting the pharmaceutical industry and enhancing human health. This review article examines the tremendous role of AI in analyzing complex biological data, optimizing research processes, and reducing costs of production. Implementation of AI in the pharmaceutical sector can store a vast dataset of manufacturing processes, identify potential disease targets, simulate physiological conditions, and predict drug interactions.
View Article and Find Full Text PDFPhilanthropic drug development: understanding its importance, mechanisms, and future prospects.
Drug Discov Today
January 2025
University Witten/Herdecke, 58455 Witten, Germany; DEBRA Research gGmbH, 80336 Munich, Germany; Knowledge House GmbH, 40213 Düsseldorf, Germany. Electronic address:
Philanthropic drug development (PDD) addresses gaps in traditional pharmaceutical innovation, particularly for rare and underserved diseases. Cost and timeline challenges discourage new investments, especially in niche therapeutic areas. Patient organizations (POs) are uniquely positioned to help to reduce development challenges by providing expertise, supporting early research, fostering collaborations, and driving patient-centered clinical trials.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!